CAS 1801415-23-5

D-Tyrosinamide, 4-chloro-L-phenylalanyl-D-cysteinyl-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-L-phenylalanyl-4-[(aminocarbonyl)amino]-D-phenylalanyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide

Description:

D-Tyrosinamide, 4-chloro-L-phenylalanyl-D-cysteinyl-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-L-phenylalanyl-4-[(aminocarbonyl)amino]-D-phenylalanyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide, identified by CAS number 1801415-23-5, is a complex peptide-like molecule characterized by its cyclic disulfide structure. This compound features multiple amino acid residues, including D-tyrosinamide, L-phenylalanine, D-cysteine, and L-lysine, contributing to its potential biological activity. The presence of a cyclic disulfide linkage suggests stability against enzymatic degradation, which is advantageous for therapeutic applications. The molecule's intricate structure may influence its solubility, reactivity, and interaction with biological targets, making it of interest in medicinal chemistry and drug design. Additionally, the incorporation of a chloro group and a pyrimidine derivative may enhance its pharmacological properties. Overall, this compound exemplifies the complexity and diversity of peptide-based molecules in the realm of biochemistry and pharmaceutical research.

Formula: C₅₈H₇₂ClN₁₅O₁₄S₂

Synonyms:

• Satoreotide
• JR11
• D-Tyrosinamide, 4-chloro-L-phenylalanyl-D-cysteinyl-4-[[[(4S)-hexahydro-2,6-dioxo-4-pyrimidinyl]carbonyl]amino]-L-phenylalanyl-4-[(aminocarbonyl)amino]-D-phenylalanyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide

Satoreotide

CAS: 1801415-23-5

Satoreotide (JR11) is an SSTR2 antagonist, typically conjugated with radiolabeled chelators for use in neuroendocrine tumor imaging [1].

Formula: C₅₈H₇₂ClN₁₅O₁₄S₂

Color and Shape: Solid

Molecular weight: 1302.87

Ref: TM-TP2620